{"id": "1375145463565852674", "creation": 1616695202.0, "user_id": "1164940374374330368", "social_network": "twitter", "nsfw": false, "request": ["b26b9dbc-1c5a-4cd3-a3a6-c2f5a51ad0fc"], "metrics": {"b26b9dbc-1c5a-4cd3-a3a6-c2f5a51ad0fc": {"retweet_count": 8, "reply_count": 2, "like_count": 43, "quote_count": 0}}, "text": "Chinese biotech Clover Biopharmaceuticals and Dynavax Technologies Corporation announced Wed the first participants have been dosed in Clover's global Phase 2/3 clinical trial of its protein-based S-Trimer #COVID19 #vaccine candidate adjuvanted with Dynavax's CpG 1018 plus alum. https://t.co/mH5MRbBlKz", "first_save": 1634559108.199414, "hashtags": ["#COVID19", "#VACCINE"]}